Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease

被引:17
作者
Facey, DA
Favaloro, EJ
Koutts, J
Berndt, MC
Hertzberg, MS [1 ]
机构
[1] Westmead Hosp, Dept Haematol, Westmead, NSW 2145, Australia
[2] Baker Inst, Hazel & Pip Appl Vasc Biol Lab, Prahran, Vic, Australia
关键词
VWF; VWD type 2B; mutation; recombinant;
D O I
10.1046/j.1365-2141.1999.01358.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2B non Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib-M-V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF Al domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF Al domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS-7 cells. Relative to wild-type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF-Al domain exists in either 'on' or 'off' states, with type 2B mutations switching VWF to an 'on' state to facilitate GPIb binding.
引用
收藏
页码:538 / 541
页数:4
相关论文
共 20 条
  • [1] CROSS-LINKING OF A MONOMERIC 39/34-KDA DISPASE FRAGMENT OF VONWILLEBRAND-FACTOR (LEU-480/VAL-481-GLY-718) TO THE N-TERMINAL REGION OF THE ALPHA-CHAIN OF MEMBRANE GLYCOPROTEIN-IB ON INTACT PLATELETS WITH BIS(SULFOSUCCINIMIDYL) SUBERATE
    ANDREWS, RK
    GORMAN, JJ
    BOOTH, WJ
    CORINO, GL
    CASTALDI, PA
    BERNDT, MC
    [J]. BIOCHEMISTRY, 1989, 28 (21) : 8326 - 8336
  • [2] IDENTIFICATION OF ASPARTIC ACID-514 THROUGH GLUTAMIC ACID-542 AS A GLYCOPROTEIN-IB-IX COMPLEX RECEPTOR RECOGNITION SEQUENCE IN VONWILLEBRAND-FACTOR - MECHANISM OF MODULATION OF VONWILLEBRAND-FACTOR BY RISTOCETIN AND BOTROCETIN
    BERNDT, MC
    WARD, CM
    BOOTH, WJ
    CASTALDI, PA
    MAZUROV, AV
    ANDREWS, RK
    [J]. BIOCHEMISTRY, 1992, 31 (45) : 11144 - 11151
  • [3] Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab
    Celikel, R
    Varughese, KI
    Madhusudan
    Yoshioka, A
    Ware, J
    Ruggeri, ZM
    [J]. NATURE STRUCTURAL BIOLOGY, 1998, 5 (03) : 189 - 194
  • [4] TYPE-IIB VONWILLEBRANDS DISEASE - GENE-MUTATIONS AND CLINICAL PRESENTATION IN 9 FAMILIES FROM DENMARK, GERMANY AND SWEDEN
    DONNER, M
    KRISTOFFERSSON, AC
    LENK, H
    SCHEIBEL, E
    DAHLBACK, B
    NILSSON, IM
    HOLMBERG, L
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 58 - 65
  • [5] Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib
    Emsley, J
    Cruz, M
    Handin, R
    Liddington, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) : 10396 - 10401
  • [6] FAVALORO EJ, 1995, AM J CLIN PATHOL, V104, P264
  • [7] DEVELOPMENT OF A SIMPLE COLLAGEN BASED ELISA ASSAY AIDS IN THE DIAGNOSIS OF, AND PERMITS SENSITIVE DISCRIMINATION BETWEEN TYPE-I AND TYPE-II, VONWILLEBRANDS DISEASE
    FAVALORO, EJ
    GRISPO, L
    EXNER, T
    KOUTTS, J
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (02) : 285 - 291
  • [8] VON-WILLEBRANDS DISEASE - LABORATORY INVESTIGATION USING AN IMPROVED FUNCTIONAL ASSAY FOR VON-WILLEBRAND-FACTOR
    FAVALORO, EJ
    GRISPO, L
    DINALE, A
    BERNDT, M
    KOUTTS, J
    [J]. PATHOLOGY, 1993, 25 (02) : 152 - 158
  • [9] GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177
  • [10] Hilbert L., 1996, British Journal of Haematology, V93, P310